Interim financial report for Q4 2020/Annual Report just released
NNIT concluded 2020 in line with the financial guidance. Q4 contributed an organic double digit, profitable growth within the Life Sciences International business. The acquisition of Excellis positively added further growth.
Acquisition-boosted Orifarm selects NNIT as new strategic IT partner
Orifarm and NNIT have signed a contract for the delivery of end-to-end IT services in connection with Orifarm’s acquisition of a significant portfolio of select over-the-counter (OTC) and prescription pharmaceutical products from Japanese pharmaceutical giant Takeda.
NNIT Group acquires Excellis Health Solutions and continues its Life Sciences growth journey
NNIT acquires US-based Excellis, a leading specialized global provider in end-to-end supply chain consulting services to the life sciences industry.
NNIT acquires Swiss-based consultancy business
Access to leading experts within life sciences IT expands NNIT’s portfolio of services to the life sciences industry.
NNIT launches new ambitious 2022 strategy with adjusted long term guidance and implements new organization
Having completed a deep strategic review throughout the second half of 2018, NNIT is now launching a new ambitious strategy. To support the new strategy, we will change the global organization in order to rapidly respond to customer needs and remain fit for accelerated growth.The fundamentals in our value proposition to our shareholders are kept intact, but with our new 2022 strategy we intensify